3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Conditions
Breast Neoplasms
15
Vitamin D Deficiency
13
Prostatic Neoplasms
13
Polycystic Ovary Syndrome
8
Neoplasms
7
Osteoporosis
4
Colorectal Neoplasms
4
Warts
3
Rectal Neoplasms
3
Ovarian Neoplasms
3
Myelodysplastic Syndromes
3
Leukemia, Lymphocytic, Chronic, B-Cell
3
Colonic Neoplasms
3
Brain Neoplasms
3
Male Urogenital Diseases
2
Leukemia
2
Cardiovascular Diseases
2
Adenomatous Polyps
2
Stroke
1
Spinal Cord Injuries
1
Skin Neoplasms
1
Seizures
1
Psoriasis
1
Prostate Adenocarcinoma
1
Premature Birth
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Polyps
1
Pathologic Processes
1
Pain
1
Osteoarthritis
1
Interventions
Zoledronic Acid
4
Denosumab
4
Aromatase Inhibitors
2
radium Ra 223 dichloride
1
Vitamin D
1
Toremifene
1
Tobacco Products
1
Letrozole
1
Hormone Replacement Therapy
1
Heart Disease Risk Factors
1
Exercise
1
Ethanol
1
Cholecalciferol
1
Cari-D-Tect
1
Aspirin
1
Anastrozole
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Completed
×
Fractures, Bone
×
Cholecalciferol
×
Clear all
NCT01646437
2021-09-16
TIPS-3
Population Health Research Institute
Phase 3
Completed
7,793 enrolled